logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/08/2025
Morgan Stanley: Gives Xpeng Motors a "buy" rating, with a target price of $28 per share on the US stock market.
Latest
4 m ago
Ningde Times Ginxiangwo mining end confirmed to stop production! Relevant sources: no short-term plans for resumption.
4 m ago
China Earthquake Networks Center automatically determined: A magnitude 6.2 earthquake occurred near the east of the Thousand Islands on August 9th at 22:04. Please refer to the official bulletin for the final result.
10 m ago
German Research Centre for Geosciences: 6.14 magnitude earthquake occurred east of the Thousand Islands Islands.
25 m ago
Wuhan sees a resurgence of "sunshine plate" with comprehensive measures to help the real estate market stabilize and accelerate.
25 m ago
Boran Biotechnology Port Stock Exchange announcement: The self-developed Bovolu injection (dulaglutide injection) has obtained market approval from the National Medical Products Administration for blood sugar control in adult type 2 diabetes patients. Bovolu is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist, and its commercialization in mainland China is carried out in cooperation with Shang Yao Holdings by the company.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.